Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 22518027)

1.

Relation between COPD severity and global cardiovascular risk in US adults.

Lee HM, Lee J, Lee K, Luo Y, Sin DD, Wong ND.

Chest. 2012 Nov;142(5):1118-25.

PMID:
22518027
2.

Does low vitamin D amplify the association of COPD with total and cardiovascular disease mortality?

Lee HM, Liu M, Lee K, Luo Y, Wong ND.

Clin Cardiol. 2014 Aug;37(8):473-8. doi: 10.1002/clc.22284. Epub 2014 Apr 9.

PMID:
24719373
3.

Preoperative spirometry results as a determinant for long-term mortality after EVAR for AAA.

Ohrlander T, Dencker M, Acosta S.

Eur J Vasc Endovasc Surg. 2012 Jan;43(1):43-7. doi: 10.1016/j.ejvs.2011.09.028. Epub 2011 Nov 2.

4.

Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.

Volpino P, Cangemi R, Fiori E, Cangemi B, De Cesare A, Corsi N, Di Cello T, Cangemi V.

J Cardiovasc Surg (Torino). 2007 Jun;48(3):375-83.

PMID:
17505444
5.

An integrated index combined by dynamic hyperinflation and exercise capacity in the prediction of morbidity and mortality in COPD.

Ozgür ES, Nayci SA, Özge C, Taşdelen B.

Respir Care. 2012 Sep;57(9):1452-9. doi: 10.4187/respcare.01440. Epub 2012 Feb 17.

6.

Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting.

Saleh HZ, Mohan K, Shaw M, Al-Rawi O, Elsayed H, Walshaw M, Chalmers JA, Fabri BM.

Eur J Cardiothorac Surg. 2012 Jul;42(1):108-13; discussion 113. doi: 10.1093/ejcts/ezr271. Epub 2012 Jan 22.

PMID:
22290913
7.

A 20-year follow-up of a population study-based COPD cohort-report from the obstructive lung disease in Northern Sweden studies.

Lundbäck B, Eriksson B, Lindberg A, Ekerljung L, Muellerova H, Larsson LG, Rönmark E.

COPD. 2009 Aug;6(4):263-71.

PMID:
19811385
8.

Cardiovascular events associated with ipratropium bromide in COPD.

Ogale SS, Lee TA, Au DH, Boudreau DM, Sullivan SD.

Chest. 2010 Jan;137(1):13-9. doi: 10.1378/chest.08-2367. Epub 2009 Apr 10.

PMID:
19363211
9.

The obesity paradox in patients with peripheral arterial disease.

Galal W, van Gestel YR, Hoeks SE, Sin DD, Winkel TA, Bax JJ, Verhagen H, Awara AM, Klein J, van Domburg RT, Poldermans D.

Chest. 2008 Nov;134(5):925-30. doi: 10.1378/chest.08-0418. Epub 2008 Jul 18.

PMID:
18641109
10.
11.

Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease.

Tantucci C, Donati P, Nicosia F, Bertella E, Redolfi S, De Vecchi M, Corda L, Grassi V, Zulli R.

Respir Med. 2008 Apr;102(4):613-9. Epub 2007 Dec 20.

12.

Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality.

Mannino DM, Diaz-Guzman E.

Chest. 2012 Jan;141(1):73-80. doi: 10.1378/chest.11-0797. Epub 2011 Jun 9.

PMID:
21659434
13.

Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity.

Finkelstein J, Cha E, Scharf SM.

Int J Chron Obstruct Pulmon Dis. 2009;4:337-49. Epub 2009 Sep 24.

14.

Risk of aortic valve replacement in patients with aortic stenosis and chronic obstructive pulmonary disease.

Spoon DB, Orszulak TA, Edell ES, Li Z, Nishimura RA.

J Heart Valve Dis. 2012 May;21(3):314-9.

PMID:
22808831
15.

Resting heart rate is a predictor of mortality in COPD.

Jensen MT, Marott JL, Lange P, Vestbo J, Schnohr P, Nielsen OW, Jensen JS, Jensen GB.

Eur Respir J. 2013 Aug;42(2):341-9. doi: 10.1183/09031936.00072212. Epub 2012 Nov 8.

16.

Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality.

Lee HM, Le H, Lee BT, Lopez VA, Wong ND.

Eur Respir J. 2010 Nov;36(5):1002-6. doi: 10.1183/09031936.00042410. Epub 2010 Jun 18.

17.

Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study.

Figarska SM, Boezen HM, Vonk JM.

Eur J Epidemiol. 2012 Nov;27(11):867-76. doi: 10.1007/s10654-012-9736-0. Epub 2012 Oct 7.

18.

Using post-bronchodilator FEV₁ is better than pre-bronchodilator FEV₁ in evaluation of COPD severity.

Chen CZ, Ou CY, Wang WL, Lee CH, Lin CC, Chang HY, Hsiue TR.

COPD. 2012 Jun;9(3):276-80. doi: 10.3109/15412555.2012.654529. Epub 2012 Feb 23.

PMID:
22360379
19.

The importance of cardiovascular disease for mortality in patients with COPD: a prognostic cohort study.

Zhang J, Rutten FH, Cramer MJ, Lammers JW, Zuithoff NP, Hoes AW.

Fam Pract. 2011 Oct;28(5):474-81. doi: 10.1093/fampra/cmr024. Epub 2011 May 20.

20.

Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study.

Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ.

Int J Chron Obstruct Pulmon Dis. 2009;4:137-48. Epub 2009 Apr 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk